p.111 抽出テキスト

259. Vutthikraivit W, Rattanawong P, Putthapiban P, et al. Worldwide Prevalence of Brugada Syndrome: A Systematic Review and Meta-Analysis. Acta Cardiol Sin 2018; 34: 267-277. PMID: 29844648 260. Milman A, Andorin A, Gourraud JB, et al. Age of First Arrhythmic Event in Brugada Syndrome: Data From the SABRUS (Survey on Arrhythmic Events in Brugada Syndrome) in 678 Patients. Circ Arrhythm Electrophysiol 2017; 10: e005222. PMID: 29254945 261. Yamakawa Y, Ishikawa T, Uchino K, et al. Prevalence of right bundle-branch block and right precordial ST-segment elevation (Brugada-type electrocardiogram) in Japanese children. Circ J 2004; 68: 275-279. PMID: 15056820 262. Oe H, Takagi M, Tanaka A, et al. Prevalence and clinical course of the juveniles with Brugada-type ECG in Japanese population. Pacing Clin Electrophysiol 2005; 28: 549-554. PMID: 15955188 263. Kamakura T, Wada M, Nakajima I, et al. Evaluation of the necessity for cardioverter-defibrillator implantation in elderly patients with Brugada syndrome. Circ Arrhythm Electrophysiol 2015; 8: 785-791. PMID: 26067668 264. Kamakura S, Ohe T, Nakazawa K, et al. Brugada Syndrome Investigators in Japan. Long-term prognosis of probands with Brugada-pattern ST-elevation in leads V1-V3. Circ Arrhythm Electrophysiol 2009; 2: 495-503. PMID: 19843917 265. Probst V, Veltmann C, Eckardt L, et al. Long-term prognosis of patients diagnosed with Brugada syndrome: Results from the FINGER Brugada Syndrome Registry. Circulation 2010; 121: 635-643. PMID: 20100972 266. Eckardt L, Probst V, Smits JP, et al. Long-term prognosis of individuals with right precordial ST-segment-elevation Brugada syndrome. Circulation 2005; 111: 257-263. PMID: 15642768 267. Priori SG, Napolitano C, Gasparini M, et al. Natural history of Brugada syndrome: insights for risk stratification and management. Circulation 2002; 105: 1342-1347. PMID: 11901046 268. Brugada J, Brugada R, Brugada P. Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest. Circulation 2003; 108: 3092-3096. PMID: 14623800 269. Brugada J, Brugada R, Antzelevitch C, et al. Long-term follow-up of individuals with the electrocardiographic pattern of right bundlebranch block and ST-segment elevation in precordial leads V1 to V3. Circulation 2002; 105: 73-78. PMID: 11772879 270. Di Diego JM, Cordeiro JM, Goodrow RJ, et al. Ionic and cellular basis for the predominance of the Brugada syndrome phenotype in males. Circulation 2002; 106: 2004-2011. PMID: 12370227 271. Shimizu W, Matsuo K, Kokubo Y, et al. Sex hormone and gender difference role of testosterone on male predominance in Brugada syndrome. J Cardiovasc Electrophysiol 2007; 18: 415-421. PMID: 17394456 272. Takagi M, Aonuma K, Sekiguchi Y, et al. Japan Idiopathic Ventricular Fibrillation Study (J-IVFS) Investigators. The prognostic value of early repolarization (J wave) and ST-segment morphology after J wave in Brugada syndrome: multicenter study in Japan. Heart Rhythm 2013; 10: 533-539. PMID: 23274366 273. Priori SG, Gasparini M, Napolitano C, et al. Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry. J Am Coll Cardiol 2012; 59: 37-45. PMID: 22192666 274. Roos M, Sarkozy A, Brodbeck J, et al. The importance of class-I antiarrhythmic drug test in the evaluation of patients with syncope: unmasking Brugada syndrome. J Cardiovasc Electrophysiol 2012; 23: 290-295. PMID: 21985403 275. Daoulah A, Alsheikh-Ali AA, Ocheltree AH, et al. Outcome after implantable cardioverter-defibrillator in patients with Brugada syndrome: the Gulf Brugada syndrome registry. J Electrocardiol 2012; 45: 327-332. PMID: 22074744 276. Sacher F, Probst V, Maury P, et al. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study-part 2. Circulation 2013; 128: 1739-1747. PMID: 23995538 277. Sieira J, Ciconte G, Conte G, et al. Asymptomatic Brugada Syndrome: Clinical Characterization and Long-Term Prognosis. Circ Arrhythm Electrophysiol 2015; 8: 1144-1150. PMID: 26215662 278. Sieira J, Conte G, Ciconte G, et al. Prognostic value of programmed electrical stimulation in Brugada syndrome: 20 years experience. Circ Arrhythm Electrophysiol 2015; 8: 777-784. PMID: 25904495 279. Casado-Arroyo R, Berne P, Rao JY, et al. Long-Term Trends in Newly Diagnosed Brugada Syndrome: Implications for Risk Stratification. J Am Coll Cardiol 2016; 68: 614-623. PMID: 27491905 280. Calò L, Giustetto C, Martino A, et al. A New Electrocardiographic Marker of Sudden Death in Brugada Syndrome: The S-Wave in Lead I. J Am Coll Cardiol 2016; 67: 1427-1440. PMID: 27012403 281. Sieira J, Ciconte G, Conte G, et al. Long-term prognosis of drug-induced Brugada syndrome. Heart Rhythm 2017; 14: 1427-1433. PMID: 28479512 282. Giustetto C, Cerrato N, Ruffino E, et al. Etiological diagnosis, prognostic significance and role of electrophysiological study in patients with Brugada ECG and syncope. Int J Cardiol 2017; 241: 188-193. PMID: 28606693 283. Ragab AAY, Houck CA, van der Does LJME, et al. Usefulness of the R-Wave Sign as a Predictor for Ventricular Tachyarrhythmia in Patients With Brugada Syndrome. Am J Cardiol 2017; 120: 428-434. PMID: 28583685 284. Morita H, Watanabe A, Kawada S, et al. Identification of electrocardiographic risk markers for the initial and recurrent episodes of ventricular fibrillation in patients with Brugada syndrome. J Cardiovasc Electrophysiol 2018; 29: 107-114. PMID: 28940628 285. Ueoka A, Morita H, Watanabe A, et al. Prognostic Significance of the Sodium Channel Blocker Test in Patients With Brugada Syndrome. J Am Heart Assoc 2018; 7: e008617. PMID: 29748178 286. Delise P, Allocca G, Sitta N, et al. Cardiac arrest and Brugada syndrome: Is drug-induced type 1 ECG pattern always a marker of low risk? Int J Cardiol 2018; 254: 142-145. PMID: 29180267 287. Pablo Flórez J, García D, Valverde I, et al. Role of syncope in predicting adverse outcomes in patients with suspected Brugada syndrome undergoing standardized flecainide testing. Europace 2018; 20: f64-f71. PMID: 29309564 288. Letsas KP, Bazoukis G, Efremidis M, et al. Clinical characteristics and long-term clinical course of patients with Brugada syndrome without previous cardiac arrest: a multiparametric risk stratification approach. Europace 2019; 21: 1911-1918. PMID: 31638693 289. Nagayama T, Nagase S, Kamakura T, et al. Clinical and Electrocardiographic Differences in Brugada Syndrome With Spontaneous or Drug-Induced Type 1 Electrocardiogram. Circ J 2019; 83: 532-539. PMID: 30643106 290. Asada S, Morita H, Watanabe A, et al. Indication and prognostic significance of programmed ventricular stimulation in asymptomatic patients with Brugada syndrome. Europace 2020; 22: 972-979. PMID: 32167564 291. Wakamiya A, Kamakura T, Shinohara T, et al. Improved Risk Stratification of Patients With Brugada Syndrome by the New Japanese Circulation Society Guideline - A Multicenter Validation Study. Circ J 2020; 84: 2158-2165. PMID: 33071242 292. Giustetto C, Nangeroni G, Cerrato N, et al. Ventricular conduction delay as marker of risk in Brugada Syndrome. Results from the analysis of clinical and electrocardiographic features of a large cohort of patients. Int J Cardiol 2020; 302: 171-177. PMID: 31771792 293. Hernandez-Ojeda J, Arbelo E, Jorda P, et al. The role of clinical assessment and electrophysiology study in Brugada syndrome patients with syncope. Am Heart J 2020; 220: 213-223. PMID: 31864099 294. Shinohara T, Takagi M, Kamakura T, et al. Japan Idiopathic Ventricular Fibrillation Study (J-IVFS) Investigators. Risk stratification in asymptomatic patients with Brugada syndrome: Utility of multiple risk factor combination rather than programmed electrical stimulation. J Cardiovasc Electrophysiol 2021; 32: 507-514. PMID: 33368830 295. Russo V, Pafundi PC, Caturano A, et al. Electrophysiological Study Prognostic Value and Long-Term Outcome in Drug-Induced Type 1 Brugada Syndrome: The IBRYD Study. JACC Clin Electrophysiol 2021; 7: 1264-1273. PMID: 33933405 296. Antzelevitch C, Yan GX, Ackerman MJ, et al. J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge. J Arrhythm 2016; 32: 315-339. PMID: 27761155 297. Veltmann C, Schimpf R, Echternach C, et al. A prospective study on spontaneous fluctuations between diagnostic and non-diagnostic ECGs in Brugada syndrome: implications for correct phenotyping and risk stratification. Eur Heart J 2006; 27: 2544-2552. PMID: 16952922 298. Scrocco C, Ben-Haim Y, Ensam B, et al. The role for ambulatory electrocardiogram monitoring in the diagnosis and prognostication of Brugada syndrome: a sub-study of the Rare Arrhythmia Syndrome Evaluation (RASE) Brugada study. Europace 2024; 26: euae091. PMID: 38584469 299. Shimizu W, Matsuo K, Takagi M, et al. Body surface distribution and response to drugs of ST segment elevation in Brugada syndrome: clinical implication of eighty-seven-lead body surface potential mapping and its application to twelve-lead electrocardiograms. J Cardiovasc Electrophysiol 2000; 11: 396-404. PMID: